ACP
VRNA

Acuta Capital Partners’s Verona Pharma VRNA Stock Holding History

Acuta Capital Partners’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,000
Closed -$378K – 43
2023
Q4 		$378K Buy
+19,000
New +$378K 0.21% 34